4.6 Article

Thromboembolic risk in patients with lung cancer receiving systemic therapy

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Hematology

Incidence, risk factors, and outcomes of venous and arterial thromboembolism in immune checkpoint inhibitor therapy

Florian Moik et al.

Summary: The study found that cancer patients undergoing therapy with immune checkpoint inhibitors were at a high risk of thromboembolism, particularly venous thromboembolism (VTE). The occurrence of VTE was associated with increased mortality. Patients with a history of VTE were more likely to develop VTE, and distant metastasis may be related to VTE risk.
Article Oncology

Incidence of thromboembolism in patients with melanoma on immune checkpoint inhibitor therapy and its adverse association with survival

Tamara A. Sussman et al.

Summary: This study found a high incidence of thromboembolism in melanoma patients receiving immune checkpoint inhibitor therapy, especially with combination regimens. Thromboembolism was associated with significantly worse survival outcomes. Further research is needed to understand the underlying mechanisms and develop preventive strategies.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)

Article Health Care Sciences & Services

Validity of Veterans Health Administration structured data to determine accurate smoking status

Sara E. Golden et al.

HEALTH INFORMATICS JOURNAL (2020)

Article Oncology

Non-Small Cell Lung Cancer, Version 5.2017 Clinical Practice Guidelines in Oncology

David S. Ettinger et al.

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2017)

Review Hematology

Cancer-associated venous thromboembolism: Burden, mechanisms, and management

Cihan Ay et al.

THROMBOSIS AND HAEMOSTASIS (2017)

Article Oncology

The International Epidemiology of Lung Cancer: Latest Trends, Disparities, and Tumor Characteristics

Ting-Yuan David Cheng et al.

JOURNAL OF THORACIC ONCOLOGY (2016)

Article Medicine, General & Internal

Pembrolizumab for the Treatment of Non-Small-Cell Lung Cancer

Edward B. Garon et al.

NEW ENGLAND JOURNAL OF MEDICINE (2015)

Article Public, Environmental & Occupational Health

The impact of comorbidity on cancer survival: a review

Mette Sogaard et al.

Clinical Epidemiology (2013)

Article Computer Science, Information Systems

Normalized names for clinical drugs: RxNorm at 6 years

Stuart J. Nelson et al.

JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION (2011)

Article Substance Abuse

Validating Smoking Data From the Veteran's Affairs Health Factors Dataset, an Electronic Data Source

Kathleen A. McGinnis et al.

NICOTINE & TOBACCO RESEARCH (2011)

Article Biophysics

Regression modeling of competing risk using R: an in depth guide for clinicians

L. Scrucca et al.

BONE MARROW TRANSPLANTATION (2010)

Article Oncology

Cisplatin-associated thrombosis

Mariam Jafri et al.

ANTI-CANCER DRUGS (2008)

Article Health Care Sciences & Services

Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data

HD Quan et al.

MEDICAL CARE (2005)

Article Medicine, General & Internal

Risk factors for deep vein thrombosis and pulmonary embolism -: A population-based case-control study

JA Heit et al.

ARCHIVES OF INTERNAL MEDICINE (2000)